Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/24/2005US6897018 DLC-1 gene deleted in cancers
05/24/2005US6897017 Vivo library-versus-library selection of optimized protein-protein interactions
05/24/2005US6896957 Magnetizable device
05/24/2005US6896906 A spray dried powder prepared by aerosolization; superior chemical and physical stability over their solution counterparts; inhaleable powder
05/24/2005US6896887 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium
05/24/2005US6896886 Administering neurotoxins; analgesics; antisecretory agent
05/24/2005US6896881 Administering a measles virus that has a nucleic acid sequence encoding a heterologous polypeptide upstream of a nucleic acid encoding a viral polypeptide, the heterolog is released from the cell, expressed anddetecting the amount
05/24/2005US6896880 Interleukins; osteoporosis therapy
05/24/2005US6896870 Diagnostic probes and therapeutics targeting uPA and uPAR
05/24/2005CA2307655C Tolerogenic fragments of natural allergens
05/24/2005CA2200935C Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
05/24/2005CA2123875C Hepatitis-c virus testing
05/24/2005CA2037607C Humanised antibodies
05/24/2005CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties
05/20/2005CA2487657A1 Specific markers for metabolic syndrome
05/20/2005CA2450297A1 Method for preventing mineralization in the periodontal ligament (pdl)
05/19/2005WO2005045428A2 Methods and compositions for modulating apoptosis
05/19/2005WO2005045056A2 Radioactive multiplexing analytical methods
05/19/2005WO2005045053A1 Process for producing lactic acid bacerium culture containing bacteriocin and method of storing food using the same
05/19/2005WO2005045044A2 Use of fibroblast growth factor fragments
05/19/2005WO2005045043A1 C/ebpalpha gene targeting constructs and uses thereof
05/19/2005WO2005045042A1 Simian orl1 gene and method of assessing compound
05/19/2005WO2005045028A1 Cell-free notch cleavage analysis method and drug screening method
05/19/2005WO2005045027A1 Wt1-origin hla-dr-binding antigen peptide
05/19/2005WO2005045021A1 Bace455, an alternative splice variant of the human beta-secretase
05/19/2005WO2005045020A2 Enzymatic synthesis, modification and decomposition of silicon(iv) compounds and other metal(iv) compounds
05/19/2005WO2005045018A1 Hybrid enzymes
05/19/2005WO2005045002A2 Nitrite-oxidizing bacteria and methods of using and detecting the same
05/19/2005WO2005044996A2 Chimeric receptors with 4-1bb stimulatory signaling domain
05/19/2005WO2005044993A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk)
05/19/2005WO2005044991A2 Compositions and methods of use for a fibroblast growth factor
05/19/2005WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
05/19/2005WO2005044987A2 Tocopherol associated protein and uses thereof
05/19/2005WO2005044982A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/19/2005WO2005044852A1 Human prostaglandin dp receptor variants and methods of using same
05/19/2005WO2005044851A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005WO2005044850A1 Helical protein zcyto32
05/19/2005WO2005044848A1 Neutralizable epitope of hgf and neutralizing antibody binding to the same
05/19/2005WO2005044847A1 Marker peptide for alzheimer’s disease
05/19/2005WO2005044846A1 Adrenomedullin 2 and use thereof
05/19/2005WO2005044845A2 Protein binding miniature proteins
05/19/2005WO2005044844A2 Protozoan strains of reduced virulence and use thereof
05/19/2005WO2005044841A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
05/19/2005WO2005044839A2 Stabilized alpha helical peptides and uses thereof
05/19/2005WO2005044838A2 Cd4+ epitopes of bone morphogenetic proteins
05/19/2005WO2005044309A1 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/19/2005WO2005044300A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica
05/19/2005WO2005044197A2 Synthesis of glycopeptides with superior pharmacokinetic properties
05/19/2005WO2005044196A2 Novel modulators of amyloid-beta production and uses thereof
05/19/2005WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
05/19/2005WO2005028656A3 Methods and compositions for enhanced plant cell transformation
05/19/2005WO2005027978A3 Albumin-binding derivatives of therapeutic peptides
05/19/2005WO2005026358A9 Polymorphisms in selenoprotein s
05/19/2005WO2005025517A9 Animal model for protease activity and liver damage
05/19/2005WO2005023855A3 K203 gene and protein
05/19/2005WO2005023288A8 Treatment of fibrotic disease
05/19/2005WO2005022160A3 Diagnosis and treatment of micobacterial infections
05/19/2005WO2005021713A8 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
05/19/2005WO2005019247A3 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
05/19/2005WO2005018542A3 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
05/19/2005WO2005017162A3 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2005014643A3 Il-11 muteins
05/19/2005WO2005014635A3 Secreted polypeptide species reduced in cardiovascular disorders
05/19/2005WO2005011732A3 Rabbit bacterium and uses thereof
05/19/2005WO2005004585A3 Precise breeding
05/19/2005WO2005003786A3 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
05/19/2005WO2004111075A8 Alternative reading frame polypeptides for treatment
05/19/2005WO2004110367A3 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
05/19/2005WO2004108755A3 Chimeric adenovirus capsid proteins
05/19/2005WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
05/19/2005WO2004106378A3 Method of treating corneal transplant rejection by using vegf antagonists
05/19/2005WO2004100997A3 Spacer moiety for poly(ethylene glycol) -modified peptides
05/19/2005WO2004100659A3 Dinoflagellate karlotoxins, methods of isolation and uses thereof
05/19/2005WO2004099246A3 Peptides for use in treating obesity
05/19/2005WO2004099240B1 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
05/19/2005WO2004099232A3 Selective r-cadherin antagonists and methods
05/19/2005WO2004098526A3 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
05/19/2005WO2004097406A3 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
05/19/2005WO2004094615A3 Prokaryotic collagen-like proteins and uses thereof
05/19/2005WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/19/2005WO2004087063A3 Use of erythropoietin in stroke recovery
05/19/2005WO2004076634A3 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
05/19/2005WO2004074448A3 mTOR KINASE-ASSOCIATED PROTEINS
05/19/2005WO2004072094A3 Hmgb1 modulator binding domain
05/19/2005WO2004053059A3 Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004039244A3 Methods and kits for diagnosing tumorigenicity
05/19/2005WO2004029222A3 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same
05/19/2005WO2004022762A9 Orthopoxvirus vectors, genes and products thereof
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005WO2004015063A3 Amplification and overexpression of oncogenes
05/19/2005WO2003106492A8 Marker for stem cells and its use
05/19/2005WO2003065873A3 Sga-1m, a cancer associated antigen, and uses thereof
05/19/2005WO2003061601A3 Aminophospholipid transporter atpase
05/19/2005WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport
05/19/2005WO2002034934A3 Stresscopins and their uses
1 ... 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 ... 2916